Form 4/A for RVMD Revolution Medicines, Inc.
Accepted 2024-06-28 00:00:00 ET · period of report 2024-06-20 · accession 0001610717-24-000375 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2024-06-28 | 2024-06-20 | RVMD | Borisy Alexis | Dir | A - Grant | $0.00 | +4,248 | 2.34M | +0.2% | $0 |
| DA | 2024-06-28 | 2024-06-20 | RVMD | Borisy Alexis | Dir | A - Grant | $0.00 | +16.0K | 16.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-20 | A | A | 4,248 | $0.00 | 2,335,742 | D | — | — | (F1) Includes 4,248 restricted stock units ("RSUs"). |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-20 | A | A | 15,955 | $0.00 | 15,955 | D | $37.54 · — to 2034-06-19 | 15,955 Common Stock | (F2) Shares subject to the Stock Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Issuer's annual meeting of stockholders following the date of grant, subject to the Reporting Person continuing in service through the vesting date. |